Skip to main content
. Author manuscript; available in PMC: 2009 Jun 8.
Published in final edited form as: J Med Chem. 2006 Jul 13;49(14):4044–4047. doi: 10.1021/jm0601250

Table 1.

Structures and Opioid Receptor Binding Affinities for Substituted 1,2,4-Triazoles

% inhibitiona
Ki (nM)b
selectivity ratio
compd R1 R2 R3 δ μ κ δ μ κ δ/μ δ/κ
1 3-OCH3 3-tert-butyl H 31 11 5 >10000 >10000 >10000 na
2 3-OH 3-tert-butyl H 91 78 66 230 850 1500 3.70 6.52
3 3-OCH3 4-tert-butyl H 8 9 8 >10000 >10000 >10000 na
4 3-OH 4-tert-butyl H 54 16 16 ∼10000 >10000 >10000 na
5 3-OH 3-phenyl H 84 84 42 140 1000 >10000 7.14 >71.4
6 3-OH 4-phenyl H 75 60 46 1500 >10000 >10000 >6.66 >6.66
7 3-OH 3,4-(CH=CH)2 H 68 48 27 2100 >10000 >10000 >4.76 >4.76
8 3-OH 4-tert-butyl N(CH3)2 94 32 6 50 4000 >10000 80 >200
9 3-OCH3 4-tert-butyl N(CH3)2 28 50 3 >10000 >10000 >10000 na
10 3-OH 3-tert-butyl N(CH3)2 76 19 6 1050 >10000 >10000 >9.5 >9.5
11 3-OH 3-phenyl N(CH3)2 86 23 8 150 >10000 >10000 >66.6 >66.6
12 3-OH 4-phenyl N(CH3)2 82 15 11 130 >10000 >10000 >76.9 >76.9
13 3-OH 3,4-(CH=CH)2 N(CH3)2 68 48 27 480 >10000 >10000 >20.8 >20.8
14 4-OH 4-tert-butyl N(CH3)2 27 8 21 >10000 >10000 >10000 na
15 3-OH 4-tert-butyl N(CH2CH2)2NCH3 18 5 12 >10000 >10000 >10000 na
16 3-OH 3-tert-butyl CH2N(CH3)2 65 27 10 2600 >10000 >10000 >3.86 >3.86
17 3-OH 4-tert-butyl CH2N(CH3)2 88 20 9 460 >10000 >10000 >21.6 >21.6
18 3-OH 4-tert-butyl (CH2)2N(CH3)2 90 23 19 900 >10000 >10000 >11.1 >11.1
a

Compounds, initially screened at 10 μM, are expressed as percentage inhibition of the reference compound which is normalized to 100%. (−)-[9−3H]bremazocine was used as the radiolabeled ligand.

b

Inhibitory effect to (−)-[9−3H]bremazocine on membranes isolated from HEK 293 cells stably transfected with mouse (δ and μ) or rat (κ) opioid receptors. Ki values are the average of two to three independent experiments.